Package 67877-731-01

{"route": ["ORAL"], "spl_id": "541259c3-7b51-4c46-a11c-f199d185ace0", "openfda": {"upc": ["0367877731018"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["19fdde81-e0f2-4269-bd57-252a759b7593"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (67877-731-01)", "package_ndc": "67877-731-01", "marketing_start_date": "20210427"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (67877-731-05)", "package_ndc": "67877-731-05", "marketing_start_date": "20210427"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (67877-731-38)  / 10 CAPSULE in 1 BLISTER PACK (67877-731-33)", "package_ndc": "67877-731-38", "marketing_start_date": "20210427"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "67877-731_541259c3-7b51-4c46-a11c-f199d185ace0", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "67877-731", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA214065", "marketing_category": "ANDA", "marketing_start_date": "20210427", "listing_expiration_date": "20261231"}